EGFR and breast cancer: Among them, monoclonal antibodies such as Trastuzumab targeting HER2 for the treatment of breast cancer and TK small molecule inhibitors such as Gefitinib and Erlotinib targeting the epidermal growth factor receptor (EGFR) for the treatment of lung cancer have shown their clinical efficacy.